Massachusetts
Life Sciences Innovation Day 2009

June 3, 2009
8:00 a.m. - 6:00 p.m.
Sheraton Boston Hotel

The Survival of the Fittest Life Sciences Companies:

How to survive in the current environment, discover new innovations, identify new markets and raise financing for great products and startups in life sciences in Massachusetts.

As we hope to show you in this program, Darwin's theory of evolution may be applied to business and technology development. Alnylam, Genzyme, BiogenIdec, Boston Scientific, Sirtris and Confluent are all companies that have evolved to become major players in the Massachusetts life sciences industry.  They all started as basic science theories - in a nurturing environment and with the work of many scientists, engineers and business executives these ideas became new products that have changed global healthcare.  At this event we'll talk about how to survive and thrive in both academic and industry research and how to see your ideas be transformed into new products. We'll look at how to Raise money... Change cultures... Chase the best ideas, as well as get a window on the future of what's new.

Keynote Presentation "Commercializing New Science" by George M. Whitesides, Professor, Harvard University and founder, Genzyme.

The 2^nd Massachusetts Life Sciences Innovation Day is the biggest day for life sciences startups and innovation in the State of Massachusetts. Last year this house-full, high-energy, hands-on event brought together legendary speakers and experts to mingle with innovators, post-docs, professors, entrepreneurs, innovators, and venture capitalists. It is the flagship event of life sciences in Massachusetts, jointly and actively put together by all the major organizations that are involved in starting and supporting the life sciences startup ecosystem in the Commonwealth.

2009 is the 150th anniversary of the publication of Charles Darwin's On the Origin of Species

Speakers include:

• James Mongan, President and CEO, Partners HealthCare
• George Whitesides, Professor, Harvard University
• Michael W. Bonney, President and CEO, Cubist Pharmaceuticals
• Mara Aspinall, Senior Advisor, Genzyme & Former President, Genzyme Genetics
• Omar Amirana, Partner, Oxford Bioscience Partners
• Joseph B. Bolen, Chief Scientific Officer, Millennium Pharmaceuticals
• Daniel Braunstein, Principal, Director of Mechanical Engineering, Design Continuum
• Jerry Brecher, President & CEO, SuturTek Incorporated
• Robert Buderi, Founder and Editor in Chief, Xconomy
• Lewis Cantley, Professor of Medicine, Harvard Medical School and Director of the Cancer Center, Beth Israel Deaconess Hospital
• Abbie Celniker, CEO, Taligen Therapeutics
• Bob Creeden, Managing Partner, Partners Innovation Fund, Partners Healthcare
• Alan Crane, Founder and CEO, Cerulean Pharmaceuticals and Partner, Polaris Ventures
• Allison Formal, Vice President, Research & Business Development, Leukemia & Lymphoma Society
• Steve Gullans, Managing Director, Excel Medical Ventures
• Hugh Herr, Director, Biomechatronics Group,MIT
• Ranch Kimball, President and CEO, Joslin Diabetes Center
• Geoff MacKay,President and Chief Executive Officer, Organogenesis
• Nagesh Mahanthappa,VP, Corporate Development & Operations
• Mark Namchuk, Vice President of Research, Vertex
• Maggie A. Pax, Vice President of Business Development, MicroCHIPS, Inc.
• Gregory A. Petsko, Professor, Brandeis University and President, American Society for Biochemistry and Molecular Biology
• Victoria Richon, Vice President, Epizyme
• Amarpreet Sawhney, President and CEO, I-Therapeutix, Inc.
• Alain Stricker-Krongrad, Chief Scientific Officer, Preclinical Services, Charles River Laboratories
• Michael Weingarten, Director, NCI Small Business Innovation Research Development Center, National Cancer Institute
• Susan R. Windham-Bannister, President and CEO, Massachusetts Life Sciences Center

We have an exciting program:

• Listen to fascinating keynote speeches and panels including  a keynote from President and CEO of Cubist Pharmaceuticals that was named the number one company by the Boston Globe in their annual Globe 100. 
• Walk around the Innovator's Marketplace where you will find everything you need to start a billion dollar life sciences company
• Meet inventors and entrepreneurs at the poster presentations
• Listen  to  captivating never-before-discussed panels on the "The Sociobiology of Life Science Cultures" and "Proof of Concept: The Missing Link" where all startup related challenges are explored
• Celebrate the 150th anniversary of "On The Origin of Species" by Charles Darwin" by attending "The Natural Selection of Life Science Start-ups" and "The Evolution of Life Science Technologies"
• Learn from the industry's top investors at the panel "Have the Rules of Getting Investment Changed?"
• Network with the Who's Who of Massachusetts life sciences. Every major stakeholder in the Commonwealth in life sciences is involved in jointly organizing this event - including the major universities, research centers and hospitals  

Conference Fees:

• $180 Academics/staff at MATTO member institutions, and Members of MBC, Mass MEDIC, TiE, MA2, CIMIT, MIT Enterprise Forum, OPEN, and WEST. 
• $225 Non-members
• $50 Students and post-docs (ID's will be required at the event)
• $500 -  Innovators' Marketplace Exhibitor (includes two attendees). Service providers will only be allocated space in the exhibit hall if they sponsor the conference - for a listing of sponsorship opportunities please visit our Sponsorship page.

About MALSI

Massachusetts Life Sciences Innovation Day has been developed by the Massachusetts Life Sciences Start-up Initiative (MALSI). MALSI is a platform organization that brings together all major public and private entities in the State that are committed to building the next generation of Massachusetts companies. MALSI's mission is to ensure that Massachusetts maintains its lead as the #1 region in the world to start, nurture and grow life sciences companies.
MALSI partners include: Massachusetts Technology Transfer Center, Mass Biotech Council, MassMEDIC, TiE Boston, and several major universities and research hospitals.

The PDF files on this page require the free Adobe Acrobat Reader.